peptide elongation factor 2 has been researched along with stilbenes in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baksh, S; Chan, AY; Dolinsky, VW; Dyck, JR; Light, PE; Soltys, CL; Viollet, B | 1 |
1 other study(ies) available for peptide elongation factor 2 and stilbenes
Article | Year |
---|---|
Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Animals; Cardiomegaly; Cardiotonic Agents; Cells, Cultured; Enzyme Activation; Enzyme Inhibitors; Mice; Multienzyme Complexes; Myocytes, Cardiac; Peptide Elongation Factor 2; Phenylephrine; Protein Biosynthesis; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Rats; Resveratrol; Ribosomal Protein S6 Kinases, 70-kDa; Stilbenes; Transcription, Genetic | 2008 |